Farname Inc. in collaboration with Iranian Society of Gynecology Oncology


1 Reproductive Health Research Center, Department of Obstetrics & Gynecology, Al-zahra Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

2 Reproductive Health Research Center , Department of Gynecology, School of Medicine, Alzahra Hospital, Guilan University of Medical Sciences, Rasht, Iran

3 Reproductive Health Research Center, Guilan University of Medical Sciences, Rasht, Iran




  1. 1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394-424. 2. Soheili F, Alizadeh S, Hassani M, Bastami P. The pathologic assessment of breast masses, before and after Menopause. Iranian J Obstet Gynecol Infertil. 2013;16(68):21-7. 3. Karimi A, Moradi Z, Sayehmiri K, Delpisheh A, Sayehmiri F. Investigation of 1 to 10-year survival of breast cancer in Iranian women: a systematic review and meta-analysis. Iranian J Obstet Gynecol Infertil. 2016;19(22):17-25. 4. Afsharfard A, Mozaffar M, Orang E, Tahmasbpour E. Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev. 2013;14(11):6905-11. 5. Ghods Elahy N. Evaluation of the possible role of oral contraceptive pills in breast cancer in Tabriz Shahid Ghazi Hospital: Tabriz University of Medical Sciences, Faculty of Pharmacy; 2019. 6. Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Pourhoseingholi A, Barzegar F, et al. Increased trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev. 2012;13(1):367-70. 7. Hippocrate A, Oussaief L, Joab I. Possible role of EBV in breast cancer and other unusually EBV-associated cancers. Cancer letters. 2011;305(2):144-9. 8. Chu PG, Chang KL, Chen Y-Y, Chen W-G, Weiss LM. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am j path. 2001;159(2):571-8. 9. Hankinson SE, Colditz GA, Willett WC. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res. 2004;6(5):213. 10. Alibek K, Kakpenova A, Mussabekova A, Sypabekova M, Karatayeva N. Role of viruses in the development of breast cancer. Infect agent cancer. 2013;8(1):1-6. 11. Al-Badry BJ, Al-Muswie RT, Jameel S, editors. Histopathological study of Human Papillomavirus (HPV) in breast cancer patients. J Phys Conf Ser; 2019: IOP Publishing. 12. Humans IWGotEoCRt. Human papillomaviruses. IARC Monographs on the evaluation of carcinogenic risks to humans. 1995;64:1. 13. Otter S, Whitaker S, Chatterjee J, Stewart A. The human papillomavirus as a common pathogen in oropharyngeal, anal and cervical cancers. Clin Oncol. 2019;31(2):81-90. 14. Chen H, Chen XZ, Waterboer T, Castro FA, Brenner H. Viral infections and colorectal cancer: a systematic review of epidemiological studies. Int J Cancer. 2015;137(1):12-24. 15. Jeannot E, Becette V, Campitelli M, Calméjane MA, Lappartient E, Ruff E, et al. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus‐associated invasive carcinoma. J Pathol Clin Res. 2016;2(4):201-9. 16. Vidone M, Alessandrini F, Marucci G, Farnedi A, de Biase D, Ricceri F, et al. Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme. Neurooncol. 2014;16(2):298-302. 17. Xiong W-M, Xu Q-P, Li X, Xiao R-D, Cai L, He F. The association between human papillomavirus infection and lung cancer: a system review and meta-analysis. Oncotarget. 2017;8(56):96419. 18. Lawson JS, Heng B. Viruses and breast cancer. Cancers. 2010;2(2):752-72. 19. Al-Kobaisi MF. Jawetz, Melnick & Adelberg’s Medical Microbiology 24th Edition. Sultan Qaboos University Medical Journal (SQUMJ). 2007;7(3):273-5. 20. Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast cancer res treat. 1992;21(2):95-100. 21. Damin AP, Karam R, Zettler CG, Caleffi M, Alexandre CO. Evidence for an association of human papillomavirus and breast carcinomas. Breast cancer res treatt. 2004;84(2):131-7. 22. Li J, Ding J, Zhai K. Detection of human papillomavirus DNA in patients with breast tumor in China. PLoS One. 2015;10(8):e0136050. 23. de Villiers E-M, Sandstrom RE, zur Hausen H, Buck CE. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res. 2004;7(1):R1. 24. Glenn WK, Whitaker NJ, Lawson JS. High risk human papillomavirus and Epstein Barr virus in human breast milk. BMC Res Notes. 2012;5(1):1-4. 25. de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat. 2008;109(1):55-8. 26. Bae J-M, Kim EH. Human papillomavirus infection and risk of breast cancer: a meta-analysis of case-control studies. Infect Agent Cancer. 2016;11(1):14. 27. Stevens-Simon C, Nelligan D, Breese P, Jenny C, Douglas JM. The prevalence of genital human papillomavirus infections in abused and nonabused preadolescent girls. Pediatr. 2000;106(4):645-9. 28. Beutner KR, Wiley DJ, Douglas JM, Tyring SK, Fife K, Trofatter K, et al. Genital warts and their treatment. Clin infect dis. 1999;28(Supplement_1):S37-S56. 29. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012;285(3):771-7. 30. Li N, Bi X, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis. Breast Cancer Res Treat. 2011;126(2):515-20. 31. Fawzy S, Sallam M, Awad NM. Detection of Epstein–Barr virus in breast carcinoma in Egyptian women. Clin biochem. 2008;41(7-8):486-92. 32. Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol. 2004;31(4):292-7. 33. Manzouri L, Salehi R, Shariatpanahi S. Prevalence of human papilloma virus among women with breast cancer since 2005-2009 in Isfahan. Adv Biomed Res. 2014;3. 34. Islam MS, Chakraborty B, Panda CK. Human papilloma virus (HPV) profiles in breast cancer: future management. Ann Transl Med. 2020;8(10). 35. de León DC, Montiel DP, Nemcova J, Mykyskova I, Turcios E, Villavicencio V, et al. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients. BMC Cancer. 2009;9(1):1-6. 36. Mendizabal-Ruiz A, Morales J, Ramirez-Jirano L, Padilla-Rosas M, Morán-Moguel M, Montoya-Fuentes H. Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat. 2009;114(1):189-94. 37. Seyedi Alavi G, Sharifi N, Sadeghian A, Jabari H, Bahreyni M, Bagheri H. Presence of human papilloma virus sequences in breast cancer tissues and association with histopathological features. Iran J Obstet Gyncol Inferti. 2009;12(2):1-4. 38. Wrede D, Luqmani Y, Coombes R, Vousden K. Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer. 1992;65(6):891-4. 39. Khodabandehlou N, Mostafaei S, Etemadi A, Ghasemi A, Payandeh M, Hadifar S, et al. Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins. BMC cancer. 2019;19(1):61. 40. Sigaroodi A, Nadji SA, Naghshvar F, Nategh R, Emami H, Velayati AA. Human papillomavirus is associated with breast cancer in the north part of Iran. Scientific World J. 2012;2012. 41. Karimi M, Khodabandehloo M, Nikkhoo B, Ghaderi E. No significant association between human papillomavirus and breast cancer, Sanandaj, Iran. Asian Pac J Cancer Prev. 2016;17(10):4741. 42. Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis. 2009;9(1):119. 43. Tabatabaei S M, Taheri Soodejani M, Shoraka H R, Mahmoudimanesh M, Eslami S, Ghaderi A. Incidence of Breast and Cervical intraepithelial Lesions: Results of a Screening Program for Women. J Obstet Gynecol Cancer Res. 2022; 7 (3) :200-205.